Showing results (1051-1060 of 2,365) with videos related to

Sort By:
Pageof 237
Future Medicinal Chemistry|December 2, 2025
Cheminformatic analysis of protein surfaces provides binding site insights and informs identification strategiesAndrej Milisavljević, Jure Pražnikar, Urban Bren, et al.
Future Medicinal Chemistry|December 18, 2024
Novel inhibitors of PARP1 and PARP14: design, synthesis, and potentiation of cisplatin efficacy in cancerCaleb M T Kam, Amanda L Tauber, Matthew S Zunk, et al.
Future Medicinal Chemistry|December 16, 2024
Novel isatin conjugates endowed with analgesic and anti-inflammatory properties: design, synthesis and biological evaluationLaVauria D Brown, Adel S Girgis, Shruti Patel, et al.
Future Medicinal Chemistry|January 29, 2025
Transition metal complexes: next-generation photosensitizers for combating Gram-positive bacteriaLingmin Pei, Xianyi Yu, Xiaoyu Shan, et al.
Future Medicinal Chemistry|January 30, 2025
Copper(II) complexes of 2-hydroxy-1-naphthaldehyde Schiff bases: synthesis, in vitro activity and computational studiesTanzeela Ahmad Shah, Aftab Alam, Zainab, et al.
Future Medicinal Chemistry|January 31, 2025
Therapeutic potential of chalcone-1,2,3-triazole hybrids as anti-tumour agents: a systematic review and SAR studiesSakshi Priya, Md Mustahidul Islam, Shivani Kasana, et al.
Future Medicinal Chemistry|February 26, 2025
Synthesis of novel quinoline-thiazolobenzimidazolone hybrids as anticancer agents through caspase-dependent apoptosisHouria Bouria, Hayette Alliouche, Mohamed Imed Chouiter, et al.
Future Medicinal Chemistry|January 17, 2025
Dual VEGFR-2 and EGFRT790M inhibitors of phenyldiazenes: anticancer evaluations, ADMET, docking, design and synthesisMarwa Alsulaimany, Ahmed K B Aljohani, Nour E A Abd El-Sattar, et al.
Future Medicinal Chemistry|March 3, 2025
Protein profiling uncovers IGF-1R inhibition potential of 3-(2-furoyl)-indole scaffolds in hepatocellular carcinomaEfficiency Myrsing, H M Chandra Mouli, Pallaprolu Nikhil, et al.
Future Medicinal Chemistry|March 4, 2025
Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraceptionJeanine Giarolla, Kelsey A Holdaway, Maryam Nazari, et al.
Pageof 237